Web-based nomogram for predicting the risk of subtherapeutic infliximab trough levels in pediatric Crohn's disease: personalized risk stratification and data-driven management of infliximab therapy

Background To develop and validate a web-based nomogram for predicting the risk of subtherapeutic infliximab trough levels (IFX-TLs) in Crohn's disease (CD), enabling personalized risk stratification and data-driven management of infliximab (IFX) therapy. Methods This retrospective analysis included 205 IFX trough measurements from 74 pediatric CD patients. Stratified sampling by patient_id was performed to split the dataset into training datasets and testing datasets at an 8:2 ratio. Least absolute shrinkage and selection operator (LASSO) regression and Boruta regression identified independent predictors. A web-based nomogram was constructed. Model performance was evaluated using the area under the receiver operating characteristic curve (AUC), calibration curves, Decision Curve Analysis (DCA), and risk stratification. SHapley Additive exPlanations (SHAP) analysis provided interpretability. Results Six independent predictors were identified: dose escalated, alkaline phosphatase (ALP), albumin (ALB), fecal calprotectin (FC), erythrocyte sedimentation rate (ESR), and Pediatric Crohn’s Disease Activity Index (PCDAI). The nomogram demonstrated good discrimination, with AUCs of 0.762 [training; 95% confidence interval (CI): 0.689–0.836] and 0.783 (testing; 95% CI: 0.609–0.956). Calibration curves showed moderate agreement, and DCA revealed a potential net clinical benefit. Risk stratification using the optimal cutoff (0.57) was able to distinguished high-risk from low-risk groups. SHAP indicated that dose escalated and ALB as protective; FC, ESR, ALP, and PCDAI as risk factors. Notably, dose escalated is an indicator of prior clinical management and should be interpreted as a surrogate of previous severity rather than a causal pharmacokinetic effect. Conclusions We successfully developed and validated a web-based nomogram to assist clinicians in predicting the risk of subtherapeutic IFX-TLs in pediatric CD, helping guide personalized and data-driven management of infliximab therapy. Compared with previously reported model, our nomogram transforms multiple predictors into an intuitive, quantifiable individual risk assessment tool, making it more convenient for physicians to use quickly in clinical settings.

Authors

Institutions

Publication Details

Journal
Frontiers in Medicine
Published
2026-11-13
DOI
https://doi.org/10.3389/fmed.2026.1837963
Primary Topic
Inflammatory Bowel Disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Web-based nomogram for predicting the risk of subtherapeutic infliximab trough levels in pediatric Crohn's disease: personalized risk stratification and data-driven management of infliximab therapy

Ting Ge, Bingxin Jiang, Siyi Zhou, Li Yunwei et al.
3 links
Frontiers in Medicine
Inflammatory Bowel Disease
article

Web-based nomogram for predicting the risk of subtherapeutic infliximab trough levels in pediatric Crohn's disease: personalized risk stratification and data-driven management of infliximab therapy

Ting Ge, Bingxin Jiang, Siyi Zhou, Li Yunwei, Xuebin Wang, Huajun Sun, Qiaoling Yang, Ting Zhang, Xiaolu Li
article en

Abstract

Background To develop and validate a web-based nomogram for predicting the risk of subtherapeutic infliximab trough levels (IFX-TLs) in Crohn's disease (CD), enabling personalized risk stratification and data-driven management of infliximab (IFX) therapy. Methods This retrospective analysis included 205 IFX trough measurements from 74 pediatric CD patients. Stratified sampling by patient_id was performed to split the dataset into training datasets and testing datasets at an 8:2 ratio. Least absolute shrinkage and selection operator (LASSO) regression and Boruta regression identified independent predictors. A web-based nomogram was constructed. Model performance was evaluated using the area under the receiver operating characteristic curve (AUC), calibration curves, Decision Curve Analysis (DCA), and risk stratification. SHapley Additive exPlanations (SHAP) analysis provided interpretability. Results Six independent predictors were identified: dose escalated, alkaline phosphatase (ALP), albumin (ALB), fecal calprotectin (FC), erythrocyte sedimentation rate (ESR), and Pediatric Crohn’s Disease Activity Index (PCDAI). The nomogram demonstrated good discrimination, with AUCs of 0.762 [training; 95% confidence interval (CI): 0.689–0.836] and 0.783 (testing; 95% CI: 0.609–0.956). Calibration curves showed moderate agreement, and DCA revealed a potential net clinical benefit. Risk stratification using the optimal cutoff (0.57) was able to distinguished high-risk from low-risk groups. SHAP indicated that dose escalated and ALB as protective; FC, ESR, ALP, and PCDAI as risk factors. Notably, dose escalated is an indicator of prior clinical management and should be interpreted as a surrogate of previous severity rather than a causal pharmacokinetic effect. Conclusions We successfully developed and validated a web-based nomogram to assist clinicians in predicting the risk of subtherapeutic IFX-TLs in pediatric CD, helping guide personalized and data-driven management of infliximab therapy. Compared with previously reported model, our nomogram transforms multiple predictors into an intuitive, quantifiable individual risk assessment tool, making it more convenient for physicians to use quickly in clinical settings.

Frontiers in MedicineVol. 13
Shanghai Jiao Tong University (CN), Kunming Children's Hospital (CN), Shanghai Children's Hospital (CN)
Good health and well-being
Inflammatory Bowel Disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon